Immix Biopharma (NASDAQ:IMMX) Coverage Initiated at Needham & Company LLCMarket Beat·Jul 22 at 07:12 AMIMMX+2.00%
Immix Biopharma posts corporate presentation highlighting NXC-201 CAR-T in relapsed/refractory AL amyloidosisPUBT·Jul 3 at 10:50 AMIMMX+2.00%
Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questionsbenzinga_article·Jun 18 at 12:38 PMIMMX+2.00%
Immix Biopharma, Inc. Stock 12‑Month Price Target Raised to $19.79, Implies 117% UpsideTradingView·Jun 18 at 08:20 AMIMMX+2.00%
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursdaybenzinga_article·Jun 18 at 06:45 AMIMMX+2.00%TRNO+0.43%
Immix Biopharma publishes corporate presentation highlighting NXC-201 CAR-T in relapsed/refractory AL amyloidosisPUBT·Jun 17 at 12:09 PMIMMX+2.00%
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common StockUnusual Whales·May 23 at 01:12 PMIMMX+2.00%IBB+0.10%
Immix Biopharma Completes $150M Underwritten Offering of Common StockUnusual Whales·May 22 at 04:16 PMIMMX+2.00%FBT-0.26%
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock | IMMX Stock NewsStockTitan·May 22 at 08:15 AMIMMX+2.00%LABU+0.27%
Immix Biopharma Prices $150 Million Underwritten Offering To Advance NXC-201 Programnasdaq·May 21 at 07:30 AMIMMX+2.00%IBB+0.10%
What's Going On With Immix Biopharma Stock Thursday?benzinga_article·May 21 at 12:16 PMIMMX+2.00%SBIO+1.11%
